Results 151 to 160 of about 3,499 (203)
Some of the next articles are maybe not open access.

Atovaquone—Proguanil Combination

2001
Development of an atovaquone—proguanil combination, trademarked Malarone, during the 1990s has been a major step in addressing the need for antimalarial drugs with targets different from those of agents for which resistance is already rampant in the field (1).
openaire   +1 more source

▼Atovaquone + proguanil for malaria prophylaxis

Drug and Therapeutics Bulletin, 2001
&#9660Atovaquone + proguanil* (Malarone - GlaxoSmithKline) is a fixed-dose combination of two antiparasitic drugs. In 1996, it was licensed in the UK for the treatment of acute, uncomplicated falciparum malaria. Earlier this year, the combination was licensed additionally for prophylaxis of falciparum malaria.
openaire   +1 more source

Atovaquone/proguanil

Reactions Weekly, 2012
openaire   +1 more source

Atovaquon/proguanil

Medisch-Farmaceutische Mededelingen, 2003
openaire   +1 more source

Atovaquone/proguanil

Reactions Weekly, 2010
openaire   +1 more source

Atovaquone/proguanil

Reactions Weekly, 2023
openaire   +1 more source

Atovaquone/proguanil

Reactions Weekly, 2006
openaire   +1 more source

Atovaquone/proguanil

Reactions Weekly, 2009
openaire   +1 more source

Home - About - Disclaimer - Privacy